Medivir AB MVR-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 05/10/21 CEST
0.808UNCH (UNCH)
52 week range
0.65 - 1.39

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.808
  • 52 Week High1.39
  • 52 Week High Date07/06/20
  • 52 Week Low0.65
  • 52 Week Low Date01/08/21

Key Stats

  • Market Cap51.64M
  • Shares Out55.74M
  • 10 Day Average Volume170
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change22.39

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.808
  • 52 Week High1.39
  • 52 Week High Date07/06/20
  • 52 Week Low0.65
  • 52 Week Low Date01/08/21
  • Market Cap51.64M
  • Shares Out55.74M
  • 10 Day Average Volume170
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change22.39

RATIOS/PROFITABILITY

  • EPS (TTM)-0.08
  • P/E (TTM)-10.10
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Medivir AB

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Medivir AB is a Sweden-based pharmaceutical research and development company with focus on oncology. The Company specializes in protease inhibitor design and nucleoside and nucleotide science, applying it to development of therapies for cancers with unmet medical need. The Company's clinical pipeline consists of remetinostat, a topical histone deacetylase (HDAC) inhibitor in phase II of clinical studies for the treatment of cutaneous T-cell lymphoma (CTCL), birinapant in...
Uli Hacksell Ph.D.
Chairman
Magnus Christensen
Chief Financial Officer
Christina Herder Ph.D.
Executive Vice President
Address
Lunastigen 7
Huddinge
14144
Sweden